{
  "catalogId": "407d25cc-f12e-45de-b580-736760b8f7eb",
  "name": "REZUROCK",
  "status": "",
  "category": "29C",
  "registrationValidity": "valid",
  "registrationNumber": "174 01 37521 99",
  "treatmentDescriptions": "Rezurock is indicated for the treatment of patients aged 12 years and older with chronic graft-versus host disease (chronic GVHD) who have received at least two prior lines of systemic therapy.",
  "termsOfIssue": "",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "BELUMOSUDIL AS MESYLATE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L04AA48",
      "name": "BELUMOSUDIL"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "REZUROCK 200 MG 30 TAB",
      "manufacturer": {
        "name": NaN,
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 30.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "21021"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": NaN,
        "retailMargin": NaN,
        "maxRetailPrice": NaN,
        "maxPriceWithVAT": NaN
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T15:46:29.680658"
  }
}